LEADER 01513nam  22004815u 450 
001 9910155281803321
005 20211006145323.0
010   $a3-318-03066-X
035   $a(CKB)3780000000102112
035   $a(OCoLC)1046110419
035   $a(SZ-BaSKA)221505
035   $a(EXLCZ)993780000000102112
100   $a20211006d1988      uy             0
101 0 $aeng
135   $aurunu|||||
200 10$aSelective 5-Ht Reuptake Inhibitors: Novel or Commonplace Agents? / $f editors, M. Gastpar, J.S. Wakelin
210   $aBasel : $cS. Karger, $d1988
215   $a1 online resource (VIII + 108 pages) : $c  20 figures, 18 tables
225 0 $aAdvances in Biological Psychiatry, $x1662-2774 ; $vVol.17
311   $a3-8055-4776-5 
517   $aSelective 5-Ht Reuptake Inhibitors
606   $aPsychiatry
606   $aPharmacology
606   $aBehavioral Research
606   $aBiochemistry
606   $aGerontology / Geriatrics
606   $aNeurology
615 14$aPsychiatry
615 14$aPharmacology
615 24$aBehavioral Research
615 24$aBiochemistry
615 24$aGerontology / Geriatrics
615 24$aNeurology
676   $a616.85/27061
700   $aGastpar$b M
701  0$aGastpar$b M$g(Markus),$f1941-$01230973
701  0$aWakelin$b J. S$g(Jennifer S.)$01230974
801  0$bUKSKG
801  1$bUKSKG
906   $aBOOK
912   $a9910155281803321
996   $aSelective 5-Ht Reuptake Inhibitors: Novel or Commonplace Agents$92858074
997   $aUNINA